Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Crowe

Showing results (191-200 of 316) with videos related to

Pageof 32
Sort By:
The Histochemical Journal|April 1, 1989
Optimizing the immunohistochemical signal from the transferrin receptor in liver tissueM Lombard, N V Naoumov, A Bomford, et al.
Hepatology (Baltimore, Md.)|January 1, 1989
Regulation of the hepatic transferrin receptor in hereditary hemochromatosisM Lombard, A Bomford, M Hynes, et al.
Journal of Strength and Conditioning Research|June 27, 2019
Effects of Various Recovery Strategies on Repeated Bouts of Simulated Intermittent ActivityFiona A Crowther, Rebecca M Sealey, Melissa J Crowe, et al.
Patient Education and Counseling|May 4, 2021
Australian patients' perception of the efficacy of the physical activity referral scheme (PARS)Francis A Albert, Aduli E O Malau-Aduli, Melissa J Crowe, et al.
International Journal of Environmental Research and Public Health|June 24, 2020
Physical Activity Promotion: A Systematic Review of The Perceptions of Healthcare ProfessionalsFrancis A Albert, Melissa J Crowe, Aduli E O Malau-Aduli, et al.
International Journal of Environmental Research and Public Health|August 27, 2021
The 'PRICE' of Physical Activity Referral Schemes (PARS): Stakeholders' Recommendations for Delivering Quality Care to PatientsFrancis A Albert, Aduli E O Malau-Aduli, Melissa J Crowe, et al.
Journal of Clinical Epidemiology|November 1, 1994
Quality of life after myocardial infarctionT K Hillers, G H Guyatt, N Oldridge, et al.
Anticancer Research|May 1, 2007
P53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse modelS E Skalicky, K Ow, M Hannan, et al.
Clinical Trials (London, England)|November 23, 2012
Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questionsJesse A Berlin, Brenda J Crowe, Edward Whalen, et al.
Gut|June 22, 2002
Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?E Ryan, V Byrnes, B Coughlan, et al.
Pageof 32

Showing results (191-200 of 316) with videos related to

Sort By:
Pageof 32
The Histochemical Journal|April 1, 1989
Optimizing the immunohistochemical signal from the transferrin receptor in liver tissueM Lombard, N V Naoumov, A Bomford, et al.
Hepatology (Baltimore, Md.)|January 1, 1989
Regulation of the hepatic transferrin receptor in hereditary hemochromatosisM Lombard, A Bomford, M Hynes, et al.
Journal of Strength and Conditioning Research|June 27, 2019
Effects of Various Recovery Strategies on Repeated Bouts of Simulated Intermittent ActivityFiona A Crowther, Rebecca M Sealey, Melissa J Crowe, et al.
Patient Education and Counseling|May 4, 2021
Australian patients' perception of the efficacy of the physical activity referral scheme (PARS)Francis A Albert, Aduli E O Malau-Aduli, Melissa J Crowe, et al.
International Journal of Environmental Research and Public Health|June 24, 2020
Physical Activity Promotion: A Systematic Review of The Perceptions of Healthcare ProfessionalsFrancis A Albert, Melissa J Crowe, Aduli E O Malau-Aduli, et al.
International Journal of Environmental Research and Public Health|August 27, 2021
The 'PRICE' of Physical Activity Referral Schemes (PARS): Stakeholders' Recommendations for Delivering Quality Care to PatientsFrancis A Albert, Aduli E O Malau-Aduli, Melissa J Crowe, et al.
Journal of Clinical Epidemiology|November 1, 1994
Quality of life after myocardial infarctionT K Hillers, G H Guyatt, N Oldridge, et al.
Anticancer Research|May 1, 2007
P53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse modelS E Skalicky, K Ow, M Hannan, et al.
Clinical Trials (London, England)|November 23, 2012
Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questionsJesse A Berlin, Brenda J Crowe, Edward Whalen, et al.
Gut|June 22, 2002
Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?E Ryan, V Byrnes, B Coughlan, et al.
Pageof 32